Polycystic ovary syndrome: What's in a name?

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages 1142-1145

  Azziz, Ricardo ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINOLOGY; FEMALE; HUMANS; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; TERMINOLOGY AS TOPIC;

EID: 84898435105     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3996     Document Type: Article

References (13)

1. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181-191.
2. NIH Office of Disease Prevention. Final report of Evidence-based Methodology Workshop on Polycystic Ovary Syndrome (PCOS). http://prevention.nih. gov/p2p/pcos/resources.aspx. Accessed Janu-ary29,2014.
3. Lobo RA. A disorder without identity: "HCA," "PCO," "PCOD," "PCOS," "SLS". What are we to call it?! Fertil Steril. 1995;63: 1158-1160.
4. Behera M, Price T, Walmer D. Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome. Fertil Steril. 2006;86:1292-1295.
5. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456-488.
6. Teede H, Gibson-Helm M, Norman RJ, Boyle J. Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome. J Clin Endocrinol Metab. 2014;99:E107-E111.
7. Azziz R. Diagnosing the diagnosis: why we must standardize the defining features of polycystic ovary syndrome. Ann Clin Biochem. 2008;45:3-5.
8. Dunaif A, Fauser BC. Renaming PCOS-a two-state solution. J Clin Endocrinol Metab. 2013;98:4325-4328.
9. Panidis D, Tziomalos K, Misichronis G, et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod. 2012;27:541-549.
10. Moghetti P, Tosi F, Bonin C, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98:E628-E637.
11. Brower M, Brennan K, Pall M, Azziz R. The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. J Clin Endocrinol Metab. 2013;98:E1967-E1971.
12. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81:19-25.
13. Ezeh U, Yildiz BO, Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. JClin En-docrinolMetab. 2013;98:E1088-E1096.